S&P 500   4,966.57 (-0.89%)
DOW   37,949.61 (+0.46%)
QQQ   414.51 (-2.10%)
AAPL   164.97 (-1.24%)
MSFT   399.04 (-1.29%)
META   480.40 (-4.26%)
GOOGL   153.83 (-1.40%)
AMZN   174.24 (-2.78%)
TSLA   147.09 (-1.89%)
NVDA   771.78 (-8.85%)
AMD   146.38 (-5.61%)
NIO   3.81 (-4.75%)
BABA   69.03 (+0.22%)
T   16.47 (+0.86%)
F   12.10 (+0.33%)
MU   106.15 (-5.16%)
GE   148.25 (-3.07%)
CGC   7.98 (+1.92%)
DIS   112.15 (-0.25%)
AMC   3.19 (+9.25%)
PFE   25.95 (+2.21%)
PYPL   61.92 (-0.29%)
XOM   119.90 (+1.16%)
S&P 500   4,966.57 (-0.89%)
DOW   37,949.61 (+0.46%)
QQQ   414.51 (-2.10%)
AAPL   164.97 (-1.24%)
MSFT   399.04 (-1.29%)
META   480.40 (-4.26%)
GOOGL   153.83 (-1.40%)
AMZN   174.24 (-2.78%)
TSLA   147.09 (-1.89%)
NVDA   771.78 (-8.85%)
AMD   146.38 (-5.61%)
NIO   3.81 (-4.75%)
BABA   69.03 (+0.22%)
T   16.47 (+0.86%)
F   12.10 (+0.33%)
MU   106.15 (-5.16%)
GE   148.25 (-3.07%)
CGC   7.98 (+1.92%)
DIS   112.15 (-0.25%)
AMC   3.19 (+9.25%)
PFE   25.95 (+2.21%)
PYPL   61.92 (-0.29%)
XOM   119.90 (+1.16%)
S&P 500   4,966.57 (-0.89%)
DOW   37,949.61 (+0.46%)
QQQ   414.51 (-2.10%)
AAPL   164.97 (-1.24%)
MSFT   399.04 (-1.29%)
META   480.40 (-4.26%)
GOOGL   153.83 (-1.40%)
AMZN   174.24 (-2.78%)
TSLA   147.09 (-1.89%)
NVDA   771.78 (-8.85%)
AMD   146.38 (-5.61%)
NIO   3.81 (-4.75%)
BABA   69.03 (+0.22%)
T   16.47 (+0.86%)
F   12.10 (+0.33%)
MU   106.15 (-5.16%)
GE   148.25 (-3.07%)
CGC   7.98 (+1.92%)
DIS   112.15 (-0.25%)
AMC   3.19 (+9.25%)
PFE   25.95 (+2.21%)
PYPL   61.92 (-0.29%)
XOM   119.90 (+1.16%)
S&P 500   4,966.57 (-0.89%)
DOW   37,949.61 (+0.46%)
QQQ   414.51 (-2.10%)
AAPL   164.97 (-1.24%)
MSFT   399.04 (-1.29%)
META   480.40 (-4.26%)
GOOGL   153.83 (-1.40%)
AMZN   174.24 (-2.78%)
TSLA   147.09 (-1.89%)
NVDA   771.78 (-8.85%)
AMD   146.38 (-5.61%)
NIO   3.81 (-4.75%)
BABA   69.03 (+0.22%)
T   16.47 (+0.86%)
F   12.10 (+0.33%)
MU   106.15 (-5.16%)
GE   148.25 (-3.07%)
CGC   7.98 (+1.92%)
DIS   112.15 (-0.25%)
AMC   3.19 (+9.25%)
PFE   25.95 (+2.21%)
PYPL   61.92 (-0.29%)
XOM   119.90 (+1.16%)
Free Trial
NYSE:BME

BlackRock Health Sciences Trust (BME) Stock Price, News & Analysis

→ Start loving Mondays like this (From DTI) (Ad)
Free BME Stock Alerts
$38.76
+0.02 (+0.05%)
(As of 03:14 PM ET)
Compare
Today's Range
$38.72
▼
$39.01
50-Day Range
$38.45
▼
$42.65
52-Week Range
$35.53
▼
$43.20
Volume
16,390 shs
Average Volume
33,447 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
6.58%
Price Target
N/A
Stock AnalysisChartCompetitorsDividendFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media
BME stock logo

About BlackRock Health Sciences Trust Stock (NYSE:BME)

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.

BME Stock Price History

BME Stock News Headlines

April 17, 2024 | msn.com
CU Boulder to offer new bachelor's degree in public health
April 14, 2024 | seekingalpha.com
BME: Discount Widens Substantially Creating An Opportunity
April 19, 2024 | DTI (Ad)
This company has increased its dividend every year for 54 years
There are three basic steps to building the Ultimate Dividend Portfolio. Step #1 is to Get The High Yields! So an index fund like the SPY, paying only 1.5% a year, isn’t going to cut it. But a company like Altria Group (MO) will.
March 28, 2024 | omaha.com
Health research needs to be higher priority for nation, science advocate says at UNMC
February 18, 2024 | seekingalpha.com
The Retiree's Dividend Portfolio - Jane's January 2024 Income Update
February 2, 2024 | benzinga.com
Blackrock Health Sciences Stock (NYSE:BME) Dividends: History, Yield and Dates
November 29, 2023 | seekingalpha.com
BME: Historically One Of The Best Times For Entry
November 13, 2023 | finance.yahoo.com
Saba Capital Management L.P. Bolsters Stake in BlackRock Health Sciences Trust II
April 19, 2024 | DTI (Ad)
This company has increased its dividend every year for 54 years
There are three basic steps to building the Ultimate Dividend Portfolio. Step #1 is to Get The High Yields! So an index fund like the SPY, paying only 1.5% a year, isn’t going to cut it. But a company like Altria Group (MO) will.
October 13, 2023 | finance.yahoo.com
Blackrock Health Sciences Trust's Dividend Analysis
September 20, 2023 | msn.com
BME: A Discounted Opportunity In The Healthcare Space
July 14, 2023 | finance.yahoo.com
BME - BlackRock Health Sciences Trust
July 8, 2023 | wsj.com
BlackRock Health Sciences Opportunities Portfolio;Investor A
April 5, 2023 | msn.com
BlackRock Health Sciences Trust (BME) Declares $0.21 Dividend
November 14, 2022 | seekingalpha.com
BlackRock Health Sciences Trust goes ex-dividend on Monday
October 15, 2022 | fool.com
Blackrock Health Sciences Trust (NYSE: BME)
August 9, 2022 | apnews.com
Health care providers suing Blue Cross/Blue Shield for antitrust violations obtain ruling that strengthens their case
May 12, 2022 | seekingalpha.com
BlackRock Health Sciences Trust goes ex-dividend tomorrow
April 11, 2022 | nasdaq.com
Ex-Dividend Reminder: BlackRock Health Sciences Trust II, BankUnited and American Financial Group
April 6, 2022 | finance.yahoo.com
We're Interested To See How Black Mountain Energy (ASX:BME) Uses Its Cash Hoard To Grow
March 5, 2022 | seekingalpha.com
BlackRock Health Sciences Trust declares $0.213 dividend
February 28, 2022 | finance.yahoo.com
Ovid Pharmaceuticals CEO details biotech pledge to cut ties with Russia
See More Headlines
Receive BME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BlackRock Health Sciences Trust and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 3/28 Dividend
3/14/2024
Dividend Payable
3/28/2024
Ex-Dividend for 4/30 Dividend
4/12/2024
Today
4/19/2024
Dividend Payable
4/30/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Financial Services
Industry
Asset Management
Sub-Industry
N/A
Current Symbol
NYSE:BME
CUSIP
N/A
CIK
1314966
Web
www2.blackrock.com
Phone
(800) 882-0052
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$20.41 million
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover
20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Charles Choon Sik Park (Age 57)
    Chief Compliance Officer and Anti-Money Laundering Officer
  • Mr. Thomas P. Callan C.F.A.
    Portfolio Manager
  • Mr. Kyle G. McClements C.F.A.
    Portfolio Manager
  • Dr. Erin Xie Ph.D. (Age 56)
    Portfolio Manager
  • Mr. Christopher M. Accettella
    Portfolio Manager
  • Mr. Jeffrey Gene Lee
    Portfolio Manager
  • Dr. Xiang Liu Ph.D.
    Portfolio Manager

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

BME Stock Analysis - Frequently Asked Questions

How have BME shares performed in 2024?

BlackRock Health Sciences Trust's stock was trading at $40.46 at the start of the year. Since then, BME shares have decreased by 3.9% and is now trading at $38.89.
View the best growth stocks for 2024 here.

Are investors shorting BlackRock Health Sciences Trust?

BlackRock Health Sciences Trust saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 8,800 shares, a drop of 35.3% from the March 15th total of 13,600 shares. Based on an average trading volume of 32,200 shares, the short-interest ratio is presently 0.3 days.
View BlackRock Health Sciences Trust's Short Interest.

How often does BlackRock Health Sciences Trust pay dividends? What is the dividend yield for BlackRock Health Sciences Trust?

BlackRock Health Sciences Trust announced a monthly dividend on Monday, April 1st. Shareholders of record on Monday, April 15th will be paid a dividend of $0.213 per share on Tuesday, April 30th. This represents a $2.56 annualized dividend and a dividend yield of 6.57%. The ex-dividend date of this dividend is Friday, April 12th.
Read our dividend analysis for BME.

Is BlackRock Health Sciences Trust a good dividend stock?

BlackRock Health Sciences Trust (NYSE:BME) pays an annual dividend of $2.55 per share and currently has a dividend yield of 0.06%.
Read our dividend analysis for BME.

What ETF holds BlackRock Health Sciences Trust's stock?

Invesco CEF Income Composite ETF holds 127,442 shares of BME stock, representing 0.67% of its portfolio.

What is Javier Hernani Burzako's approval rating as BlackRock Health Sciences Trust's CEO?

3 employees have rated BlackRock Health Sciences Trust Chief Executive Officer Javier Hernani Burzako on Glassdoor.com. Javier Hernani Burzako has an approval rating of 100% among the company's employees. This puts Javier Hernani Burzako in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of BlackRock Health Sciences Trust own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BlackRock Health Sciences Trust investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), AT&T (T), Gilead Sciences (GILD), International Business Machines (IBM), Johnson & Johnson (JNJ), Verizon Communications (VZ), Exxon Mobil (XOM), Alibaba Group (BABA) and Procter & Gamble (PG).

Who are BlackRock Health Sciences Trust's major shareholders?

BlackRock Health Sciences Trust's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Nova R Wealth Inc. (0.00%) and NBC Securities Inc. (0.00%).
View institutional ownership trends.

How do I buy shares of BlackRock Health Sciences Trust?

Shares of BME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:BME) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
Your Money is Not Safe
American Alternative
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media
My biggest AI fear
Paradigm Press